James Emmett Young Med Tech Acquisition Corp (MTACW) insider trading activity

MTACW Quotes by TradingView

James Emmett Young is Chief Financial Officer of MedTech Acquisition Corp. Currently has a direct ownership of 49,663 shares of MTACW, which is worth approximately $10,925. The most recent transaction as insider was on May 19, 2025, when has been sold 13,175 shares (Common Stock) at a price of $5.18 per share, resulting in proceeds of $68,246. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.7K
36.11% 3M change
n/a 12M change
Total Value Held $10,925

James Emmett Young Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2025
BUY
Grant, award, or other acquisition
$68,246 $5.18 p/Share
13,175 Added 20.97%
49,663 Common Stock
Feb 18 2025
BUY
Grant, award, or other acquisition
-
14,762 Added 28.8%
36,488 Common Stock
Jan 27 2025
BUY
Grant, award, or other acquisition
-
12,500 Added 36.52%
21,726 Common Stock
JEY

James Emmett Young

Chief Financial Officer
Westminster, CO

Track Institutional and Insider Activities on MTACW

Follow MedTech Acquisition Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTACW shares.

Notify only if

Insider Trading

Get notified when an Med Tech Acquisition Corp insider buys or sells MTACW shares.

Notify only if

News

Receive news related to MedTech Acquisition Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MTACW